Berlin, Germany

Gunter Stock

USPTO Granted Patents = 2 

Average Co-Inventor Count = 5.3

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1986-1987

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Gunter Stock in Geriatric Medicine

Introduction

Gunter Stock, an accomplished inventor based in Berlin, Germany, has made significant contributions to the field of geriatric medicine. With two patents to his name, he is recognized for his innovative approaches to treating age-related health concerns. His work is indicative of the impactful advancements that occur when diligent research meets the needs of an aging population.

Latest Patents

Gunter Stock's latest patents exhibit his commitment to improving geriatric healthcare. His first patent focuses on the "Use of Terguride as a Geriatric Agent." This invention demonstrates that Terguride, along with its physiologically compatible salts, can be effectively utilized for treating geriatric deficiencies, particularly in dosages ranging from 0.1 to 5.0 mg/day. His second patent highlights Terguride's application as an antihypertensive agent, revealing its efficacy in managing essential hypertonia in humans with dosages between 0.1 to 1.0 mg/day.

Career Highlights

Gunter Stock's career has been marked by his role at Schering Aktiengesellschaft, a company renowned for its contributions to pharmaceutical innovation. His work there has positioned him as a key player in addressing critical health issues faced by the elderly. His relentless pursuit of groundbreaking solutions underlines his dedication to improving patient outcomes through scientific advancements.

Collaborations

Throughout his career, Gunter has collaborated with notable colleagues like Wolfgang Kehr and Helmut Wachtel. These partnerships have enriched his research endeavors and allowed for the exchange of ideas, fostering a collaborative environment that is essential for innovation in the medical field.

Conclusion

In summary, Gunter Stock stands out as a pivotal figure in the domain of geriatric medicine, leveraging his innovative spirit to develop solutions that cater to an aging population. His patents on Terguride signify not only his scientific expertise but also his commitment to enhancing the quality of life for seniors. Through his work at Schering Aktiengesellschaft and collaborations with esteemed colleagues, Gunter Stock continues to inspire the next generation of inventors in the healthcare sector.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…